Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6778)
All Articles published online
|
Publishing Process of This Article
|
Oct 18, 2013 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Orthopedics
ISSN
2218-5836
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yoneda T, Tanaka S, Hata K. Role of RANKL/RANK in primary and secondary breast cancer. World J Orthop 2013; 4(4): 178-185 [PMID: 24147253 DOI: 10.5312/wjo.v4.i4.178] |
|---|---|
| URL: | https://www.wjgnet.com/2218-5836/full/v4/i4/178.htm |
| Number | Citing Articles |
| 1 |
Bongkun Choi, Eun-Ju Chang. Biomarkers in Bone Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2016; : 1 doi: 10.1007/978-94-007-7745-3_40-1
|
| 2 |
Zhengxiao Ouyang, Xiaoning Guo, Xia Chen, Bo Liu, Qiang Zhang, Ziqing Yin, Zanjing Zhai, Xinhua Qu, Xuqiang Liu, Dan Peng, Yi Shen, Tang Liu, Qing Zhang. Hypericin targets osteoclast and prevents breast cancer-induced bone metastasis via NFATc1 signaling pathway. Oncotarget 2018; 9(2): 1868 doi: 10.18632/oncotarget.22930
|
| 3 |
Raúl M. Luque, Laura M. López-Sánchez, Alicia Villa-Osaba, Isabel M. Luque, Ana L. Santos-Romero, Elena M. Yubero-Serrano, María Cara-García, Marina Álvarez-Benito, José López-Miranda, Manuel D. Gahete, Justo P. Castaño. Breast cancer is associated to impaired glucose/insulin homeostasis in premenopausal obese/overweight patients. Oncotarget 2017; 8(46): 81462 doi: 10.18632/oncotarget.20399
|
| 4 |
Bora Kim, Yong Jin Cho, Mineon Park, Wonbong Lim. Immunization With RANKL Inhibits Osteolytic Bone Metastasis in Breast Cancer. Journal of Immunotherapy 2022; 45(1): 1 doi: 10.1097/CJI.0000000000000393
|
| 5 |
Franco Lumachi, Stefano M. M. Basso. Calcium: Chemistry, Analysis, Function and Effects. 2015; : 605 doi: 10.1039/9781782622130-00605
|
| 6 |
Subrata K Pore, Eun-Ryeong Hahm, Joseph D Latoche, Carolyn J Anderson, Yongli Shuai, Shivendra V Singh. Prevention of breast cancer-induced osteolytic bone resorption by benzyl isothiocyanate. Carcinogenesis 2018; 39(2): 134 doi: 10.1093/carcin/bgx114
|
| 7 |
Riko Kitazawa, Ryuma Haraguchi, Mana Fukushima, Sohei Kitazawa. Pathologic conditions of hard tissue: role of osteoclasts in osteolytic lesion. Histochemistry and Cell Biology 2018; 149(4): 405 doi: 10.1007/s00418-018-1639-z
|
| 8 |
R. Ajina, D. AlDeghaither, S. Jablonski, L.M. Weiner. Comprehensive Medicinal Chemistry III. 2017; : 32 doi: 10.1016/B978-0-12-409547-2.12426-6
|
| 9 |
Suruchi Mittal, Nicola J. Brown, Ingunn Holen. The breast tumor microenvironment: role in cancer development, progression and response to therapy. Expert Review of Molecular Diagnostics 2018; 18(3): 227 doi: 10.1080/14737159.2018.1439382
|
| 10 |
Hongwei Zhang. Bone Microenvironment and Role of Rank-Rankl-Opg in Breast Cancer Metastasis in Bone. Journal of Cancer Prevention & Current Research 2017; 7(3) doi: 10.15406/jcpcr.2017.07.00234
|
| 11 |
Kemal Behzatoglu. Osteoclasts in Tumor Biology: Metastasis and Epithelial-Mesenchymal-Myeloid Transition. Pathology and Oncology Research 2021; 27 doi: 10.3389/pore.2021.609472
|
| 12 |
CHIA-JUNG HSIEH, PO-LIN KUO, MING-FENG HOU, JEN-YU HUNG, FANG-RONG CHANG, YING-CHAN HSU, YA-FANG HUANG, EING-MEI TSAI, YA-LING HSU. Wedelolactone inhibits breast cancer-induced osteoclastogenesis by decreasing Akt/mTOR signaling. International Journal of Oncology 2015; 46(2): 555 doi: 10.3892/ijo.2014.2769
|
| 13 |
Bongkun Choi, Eun-Ju Chang. Biomarkers in Bone Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2017; : 253 doi: 10.1007/978-94-007-7693-7_40
|
| 14 |
Purushoth Ethiraj, Yuvaraj Sambandam, Jessica D. Hathaway‐Schrader, Azizul Haque, Chad M. Novince, Sakamuri V. Reddy. RANKL triggers resistance to TRAIL‐induced cell death in oral squamous cell carcinoma. Journal of Cellular Physiology 2020; 235(2): 1663 doi: 10.1002/jcp.29086
|
| 15 |
Andy C-M Chang, Judy Doherty, Lily I. Huschtscha, Richard Redvers, Christina Restall, Roger R. Reddel, Robin L. Anderson. STC1 expression is associated with tumor growth and metastasis in breast cancer. Clinical & Experimental Metastasis 2015; 32(1): 15 doi: 10.1007/s10585-014-9687-9
|
| 16 |
Toshiyuki Yoneda, Masahiro Hiasa, Yuki Nagata, Tatsuo Okui, Fletcher A White. Acidic microenvironment and bone pain in cancer-colonized bone. BoneKEy Reports 2015; 4 doi: 10.1038/bonekey.2015.58
|
| 17 |
Toshiyuki Yoneda, Masahiro Hiasa, Yuki Nagata, Tatsuo Okui, Fletcher White. Contribution of acidic extracellular microenvironment of cancer-colonized bone to bone pain. Biochimica et Biophysica Acta (BBA) - Biomembranes 2015; 1848(10): 2677 doi: 10.1016/j.bbamem.2015.02.004
|
| 18 |
Ludwig Kiesel, Annemarie Kohl. Role of the RANK/RANKL pathway in breast cancer. Maturitas 2016; 86: 10 doi: 10.1016/j.maturitas.2016.01.001
|
| 19 |
Yuvaraj Sambandam, Purushoth Ethiraj, Jessica D. Hathaway‐Schrader, Chad M. Novince, Ezhil Panneerselvam, Kumaran Sundaram, Sakamuri V. Reddy. Autoregulation of RANK ligand in oral squamous cell carcinoma tumor cells. Journal of Cellular Physiology 2018; 233(8): 6125 doi: 10.1002/jcp.26456
|
| 20 |
Xiaoqiu Wu, Fangfei Li, Lei Dang, Chao Liang, Aiping Lu, Ge Zhang. RANKL/RANK System-Based Mechanism for Breast Cancer Bone Metastasis and Related Therapeutic Strategies. Frontiers in Cell and Developmental Biology 2020; 8 doi: 10.3389/fcell.2020.00076
|
| 21 |
Hiroki Wakabayashi, Satoshi Wakisaka, Toru Hiraga, Kenji Hata, Riko Nishimura, Makoto Tominaga, Toshiyuki Yoneda. Decreased sensory nerve excitation and bone pain associated with mouse Lewis lung cancer in TRPV1-deficient mice. Journal of Bone and Mineral Metabolism 2018; 36(3): 274 doi: 10.1007/s00774-017-0842-7
|
| 22 |
|
| 23 |
Michael AB Naafs. Parathyroid Hormone Related Peptide (PTHrP): A Mini-Review. Endocrinology&Metabolism International Journal 2017; 5(6) doi: 10.15406/emij.2017.05.00139
|
| 24 |
Bongkun Choi, Eun-Jin Lee, Da-Hyun Song, Sung-Chul Yoon, Yeon-Ho Chung, Youngsaeng Jang, Sang-Min Kim, Youngsup Song, Sang-Wook Kang, Seung-Yong Yoon, Eun-Ju Chang. Elevated Pentraxin 3 in bone metastatic breast cancer is correlated with osteolytic function. Oncotarget 2014; 5(2): 481 doi: 10.18632/oncotarget.1664
|
| 25 |
Toru Hiraga. Targeted Agents in Preclinical and Early Clinical Development for the Treatment of Cancer Bone Metastases. Expert Opinion on Investigational Drugs 2016; 25(3): 319 doi: 10.1517/13543784.2016.1142972
|
| 26 |
Petr Lapcik, Anna Pospisilova, Lucia Janacova, Peter Grell, Pavel Fabian, Pavel Bouchal. How Different Are the Molecular Mechanisms of Nodal and Distant Metastasis in Luminal A Breast Cancer?. Cancers 2020; 12(9): 2638 doi: 10.3390/cancers12092638
|
| 27 |
Ya-Ling Hsu, Eing-Mei Tsai, Ming-Feng Hou, Tsu-Nai Wang, Jen-Yu Hung, Po-Lin Kuo. Obtusifolin Suppresses Phthalate Esters-Induced Breast Cancer Bone Metastasis by Targeting Parathyroid Hormone-Related Protein. Journal of Agricultural and Food Chemistry 2014; 62(49): 11933 doi: 10.1021/jf5042905
|
| 28 |
Yuvaraj Sambandam, Sashank Sakamuri, Sundaravadivel Balasubramanian, Azizul Haque. RANK Ligand Modulation of Autophagy in Oral Squamous Cell Carcinoma Tumor Cells. Journal of Cellular Biochemistry 2016; 117(1): 118 doi: 10.1002/jcb.25255
|